As experts are discovering more about genetic profiling and prognostic factors for multiple myeloma, what questions should patients ask their doctor about testing? At the 2019 American Society of Hematology (ASH) annual meeting, Dr. James Berenson discusses the recommended testing to receive a genetic diagnosis and some mutations seen in myeloma. Can mutational status impact treatment outcomes? Watch as Dr. Berenson also shares research on response for patients with specific genetic markers, and how this may influence treatment decision-making.